Arch Venture Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Arch Venture Management’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-126,630	Closed	-$2.46M	–	10
2024 Q4	$2.46M	Hold	126,630	–	–	1.07%	6
2024 Q3	$1.98M	Hold	126,630	–	–	0.76%	7
2024 Q2	$1.07M	Sell	126,630 -1	-0%	-$12	0.4%	8
2024 Q1	$1.95M	Hold	126,631	–	–	2.43%	7
2023 Q4	$1.75M	Hold	126,631	–	–	1.07%	7
2023 Q3	$1.45M	Hold	126,631	–	–	0.94%	7
2023 Q2	$3.15M	Hold	126,631	–	–	1.95%	5
2023 Q1	$4.6M	Hold	126,631	–	–	2.22%	6
2022 Q4	$7.64M	Hold	126,631	–	–	1.96%	6
2022 Q3	$9.5M	Hold	126,631	–	–	1.23%	7
2022 Q2	$14.5M	Hold	126,631	–	–	1.77%	6
2022 Q1	$24M	Hold	126,631	–	–	3.43%	5
2021 Q4	$43.9M	Buy	+126,631	New	+$49.1M	4.65%	5

Arch Venture Management's OMIC Position: Q1 2025 in Review

Arch Venture Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2025, closing a stake of 126,630 shares — an estimated $2.46M sold.

Arch Venture Management first reported a position in OMIC in Q4 2021 and held it in 13 quarters. The position peaked at $43.9M in Q4 2021. 0 funds tracked by Wall St. Rank hold OMIC as of Q1 2025.

Arch Venture Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Arch Venture Management sold 126,630 Singular Genomics Systems, Inc. Common Stock shares in Q1 2025, an estimated $2.46M.
Arch Venture Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 13 quarters.
Arch Venture Management's Singular Genomics Systems, Inc. Common Stock position peaked at $43.9M in Q4 2021.
0 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2025.

Based on Arch Venture Management's 13F filing for Q1 2025, filed 15 May 2025.